Top Questions of the Day in March At T1D Exchange, we learn something new from our Online Community by asking a “Question of the Day,” every single day. People living with T1D can learn so much from the shared experiences of others. Consider sharing our Online Community with T1D friends, so they can be part of a community that “gets it,” too. Last month’s Top Questions: At what age were you (or a loved one) diagnosed with T1D? How many times a year do you miss planned events because of something T1D-related? When you go away for the weekend (2 nights), how many low snacks do you bring with yo ..read more

Latent autoimmune diabetes in adults, or LADA, is an atypical type of diabetes. Meaning, it has features of both type 1 diabetes (T1D) and type 2 diabetes (T2D). At first, LADA looks a lot like T2D, but over time, insulin production diminishes. That’s because LADA is a slow, progressive form of autoimmune diabetes primarily occurring in adults. Like a person with T1D, those with LADA produce autoantibodies against their insulin-producing beta cells, which is why it is often mistaken for and misdiagnosed as T2D. Research suggests about 10% of adults living with LADA are initially misdiagnosed w ..read more

Around 1% of the world’s population has autism spectrum disorder. It is the most common developmental disability in the world. While people “on the spectrum” can manifest the condition differently, we’re united by many commonalities and concomitant conditions. As an autistic person, and parent of an adolescent who lives with autism and type 1 diabetes (T1D), I observe first-hand how autism affects our way of interacting with the world, and how developing effective coping mechanisms is essential for how well we operate in society. Right now, the relationship between autism and T1D isn’t quite c ..read more

Autoimmunity: The Breakdown   In honor of National Autoimmune Awareness Month, T1D Exchange would like to raise awareness and understanding of other autoimmune diseases affecting our community.   Did you know having one autoimmune condition places you at higher risk of developing another? Research suggests about one in every five people who live with type 1 diabetes (T1D) go on to develop another autoimmune condition in their lifetime.   While experts continue to learn more about autoimmune disease, for now, they are not entirely sure why it happens. If you live w ..read more

People living with type 2 diabetes (T2D) face a disproportionately higher risk of cardiovascular disease (CVD), leading to increased morbidity and mortality. This highlights the critical need for prevention and management efforts, as emphasized by the American Heart Association (AHA). With focused efforts to address heart and vascular health, the Know Diabetes by Heart initiative provides a promising path forward for over 30 million people living with T2D in the United States.” “When lifestyle management, diabetes mellitus care, and CVD risk management are optimally delivered to individuals wi ..read more

Pump Users: Meet Gluroo    Meet Gluroo, a new, free, collaborative diabetes management app that’s available for download.   Gluroo, which was built out of necessity by an innovative type 1 diabetes (T1D) dad, connects approved devices to users’ real-time data and actions with loved ones and their healthcare providers. What’s more, Gluroo is constructed for people living with all types of diabetes, so this app can make navigating life with diabetes easier for everyone.  Badros explained when his son, Jax, was diagnosed with T1D at 7 years old, he started on a cont ..read more

Our mission at the T1D Exchange is to improve the lives of people living with type 1 diabetes (T1D). A large part of how we accomplish this mission is through research. At the T1D Exchange, our Outcomes Research team collaborates with leaders in the T1D space and with other experts at the T1D Exchange to design studies to understand the preferences, experiences, and quality of life of people living with T1D in our Registry and Online Community. If you are a part of the Registry, you’ve likely seen study opportunities pop up on your dashboard. You may have even participated in some of these stu ..read more

Ebekozien, O, Maahs, D, Lyons, S, Rompicherla, S, Mungmode, A, Herrick, C, Levy, C, Alonso, G.T, Rapaport, R Background and Aims: In the last decade, there have been major innovations in the clinical management for people with type 1 diabetes (PwT1D). We analyzed trends in glycemic outcomes and diabetes technologies use stratified by age, insurance, and race‐ethnicity across the T1D Exchange Quality Improvement (T1DX‐QI) multi‐center collaborative. Methods: T1DX‐QI is a quality improvement learning network of electronic medical record data sharing diabetes centers in the U.S. The ana ..read more

Ebekozien, O, Ospelt, E, Odugbesan, O, Clements, M, Rao, P, Guarneri, A, Kellis, M, Rapaport, R, Sonabend, R, Addala, A Background and Aims: Automated Insulin Delivery (AID) has been demonstrated to improve glycemic outcomes, reduce acute complications, and improve quality of life for people with type 1 diabetes (PwT1D). This study aims to describe the relative importance of patient factors considered by diabetes providers in recommending AID to PwT1D. Methods: A modified 24‐item Diabetes Provider Implicit Bias (D‐PIB) online survey was distributed between March 2023 – July 2023 to a ..read more

At T1D Exchange, we learn something new from our Online Community by asking a “Question of the Day,” every single day. Consider connecting your T1D friends with our Online Community, so they can be part of a community that gets it, too.   This month’s Top Questions: What is your primary connection to the T1D community? Where do you order your continuous glucose monitors (CGMs) from? How much of your total amount of insulin is your basal insulin? (*Comments have been edited slightly for clarity as needed.)     What is your primary connection to the T1D community? Here are ..read more